image description
MTAs protect UW intellectual property rights, limit UW liability, and fairly credit the developer of the materials.


What’s a Material Transfer Agreement (MTA)?

Material Transfer Agreements (MTAs) are contracts that protect your IP when you either provide or receive research materials—such as cell lines, cultures, bacteria, nucleotides, proteins, transgenic animals, pharmaceuticals, and chemicals—to and from research institutions or corporate entities. Each exchange of research material requires an MTA. For repeated exchanges of the same research material, standardized MTAs can help streamline the process. C4C’s Agreements Group can help you efficiently transfer research materials.

Why are MTAs important?

MTAs are important because they protect your IP rights, limit liability, and fairly credit the developer of the materials.

Who should I contact for assistance with MTAs?

UW researchers should contact the UW C4C Agreements Group: 206-543-3970,

If the MTA is embedded in a Sponsored Research Agreement, is linked to a clinical trial, or is for clinical use or clinical studies in humans, then the Office of Sponsored Programs (OSP) is responsible for the MTA. The UW Center for Commercialization and OSP are the only units of the UW authorized to review and sign MTAs.

MTA Procedures:

Outgoing not-for-profit MTAs

To request an MTA for biological materials from the UW, please complete this form.

Outgoing for-profit MTAs

C4C’s Agreements Group reviews for-profit MTAs with you to determine the most appropriate document for the transfer of materials. See detailed steps.

Incoming MTAs

C4C’s Agreements Group can help you complete incoming materials transfers, starting with these steps.

Transfer of human biological material

UW School of Medicine maintains a strict policy regarding the transfer of human biological material—any material that comes from a person—to third parties. See detailed instructions.